human osteosarcoma mg63 cells Search Results


human osteosarcoma cell line mg63  (Shanghai iCELL Biotechnology Co Ltd)
90
Shanghai iCELL Biotechnology Co Ltd human osteosarcoma cell line mg63
Human Osteosarcoma Cell Line Mg63, supplied by Shanghai iCELL Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell line mg63/product/Shanghai iCELL Biotechnology Co Ltd
Average 90 stars, based on 1 article reviews
human osteosarcoma cell line mg63 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human osteosarcoma cells (mg63  (Merck & Co)
90
Merck & Co human osteosarcoma cells (mg63
Indirect cytotoxicity profile on HDF and <t>MG63</t> after treatment with 20% DMSO, PLGA, RIF:PLGA (1:8) and RIF:PLGA (1:2). The data shown represent average ± SD of 3 independent experiments normalised to the control value of cell line without treatment, which was set at 100%. (*** p < 0.001).
Human Osteosarcoma Cells (Mg63, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cells (mg63/product/Merck & Co
Average 90 stars, based on 1 article reviews
human osteosarcoma cells (mg63 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human osteosarcoma cell lines hos, saos-2 and mg63  (Servicebio Inc)
90
Servicebio Inc human osteosarcoma cell lines hos, saos-2 and mg63
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Cell Lines Hos, Saos 2 And Mg63, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell lines hos, saos-2 and mg63/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
human osteosarcoma cell lines hos, saos-2 and mg63 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human osteosarcoma cell line mg63  (ProMab Inc)
90
ProMab Inc human osteosarcoma cell line mg63
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Cell Line Mg63, supplied by ProMab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell line mg63/product/ProMab Inc
Average 90 stars, based on 1 article reviews
human osteosarcoma cell line mg63 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human osteosarcoma cell lines mg63 and hos te85 (hos)  (Stanmore Implants Worldwide Ltd)
90
Stanmore Implants Worldwide Ltd human osteosarcoma cell lines mg63 and hos te85 (hos)
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Cell Lines Mg63 And Hos Te85 (Hos), supplied by Stanmore Implants Worldwide Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell lines mg63 and hos te85 (hos)/product/Stanmore Implants Worldwide Ltd
Average 90 stars, based on 1 article reviews
human osteosarcoma cell lines mg63 and hos te85 (hos) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human osteosarcoma mg63 cells  (Federation of European Neuroscience Societies)
90
Federation of European Neuroscience Societies human osteosarcoma mg63 cells
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Mg63 Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma mg63 cells/product/Federation of European Neuroscience Societies
Average 90 stars, based on 1 article reviews
human osteosarcoma mg63 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human mg63 osteosarcoma cells  (Ludwig Boltzmann Gesellschaft)
90
Ludwig Boltzmann Gesellschaft human mg63 osteosarcoma cells
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Mg63 Osteosarcoma Cells, supplied by Ludwig Boltzmann Gesellschaft, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mg63 osteosarcoma cells/product/Ludwig Boltzmann Gesellschaft
Average 90 stars, based on 1 article reviews
human mg63 osteosarcoma cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Indirect cytotoxicity profile on HDF and MG63 after treatment with 20% DMSO, PLGA, RIF:PLGA (1:8) and RIF:PLGA (1:2). The data shown represent average ± SD of 3 independent experiments normalised to the control value of cell line without treatment, which was set at 100%. (*** p < 0.001).

Journal: Pharmaceutics

Article Title: Formulation, Characterisation, and Biocompatibility Assessment of Rifampicin-Loaded Poly(d,l-lactide-co-glycolide) Composites for Local Treatment of Orthopaedic and Wound Infections

doi: 10.3390/pharmaceutics16111467

Figure Lengend Snippet: Indirect cytotoxicity profile on HDF and MG63 after treatment with 20% DMSO, PLGA, RIF:PLGA (1:8) and RIF:PLGA (1:2). The data shown represent average ± SD of 3 independent experiments normalised to the control value of cell line without treatment, which was set at 100%. (*** p < 0.001).

Article Snippet: Human dermal fibroblast (HDF) cells were procured from Caltag Medsystems (Buckingham, UK), and human osteosarcoma cells (MG63) were obtained from Merck (Dorset, UK).

Techniques: Control

Direct cytotoxicity profile on MG63 after treatment with 20% DMSO, PLGA, RIF:PLGA (1:8) and RIF:PLGA (1:2). The data shown represent average ± SD of 3 independent experiments normalised to the control value of cell line without treatment, which was set at 100%. (*** p < 0.001, ns—non-significant).

Journal: Pharmaceutics

Article Title: Formulation, Characterisation, and Biocompatibility Assessment of Rifampicin-Loaded Poly(d,l-lactide-co-glycolide) Composites for Local Treatment of Orthopaedic and Wound Infections

doi: 10.3390/pharmaceutics16111467

Figure Lengend Snippet: Direct cytotoxicity profile on MG63 after treatment with 20% DMSO, PLGA, RIF:PLGA (1:8) and RIF:PLGA (1:2). The data shown represent average ± SD of 3 independent experiments normalised to the control value of cell line without treatment, which was set at 100%. (*** p < 0.001, ns—non-significant).

Article Snippet: Human dermal fibroblast (HDF) cells were procured from Caltag Medsystems (Buckingham, UK), and human osteosarcoma cells (MG63) were obtained from Merck (Dorset, UK).

Techniques: Control

SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, MG63, U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Journal of Translational Medicine

Article Title: SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma

doi: 10.1186/s12967-024-05803-6

Figure Lengend Snippet: SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, MG63, U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The human osteosarcoma cell lines HOS, Saos-2 and MG63 were purchased from Wuhan Servicebio Technology Co., Ltd.

Techniques: Expressing, Western Blot